Medicine and Dentistry
Ovarian Cancer
100%
Germ Cell
83%
PARP Inhibitor
66%
Copy Number Variation
50%
Pedigree
50%
Liquid Biopsy
50%
Homologous Recombination
50%
Combination Therapy
50%
Familial Pancreatic Cancer
50%
Gene Mutation
50%
Breast Cancer
50%
Retinitis pigmentosa
50%
Next Generation Sequencing
40%
BRCA1
33%
Genetic Screening
16%
Cancer Susceptibility
16%
Cancer Prevention
16%
Personalized Medicine
16%
Cell-Free DNA
16%
Multiplex Ligation Dependent Probe Amplification
15%
Immune Checkpoint Inhibitor
8%
Recombination Repair
8%
Angiogenesis Inhibitor
8%
False Positive Result
5%
Retina Dystrophy
5%
Keyphrases
Pedigree
50%
Hereditary Ovarian Cancer
50%
Medical Management
50%
Liquid Biopsy
50%
Hereditary Breast Cancer
50%
Online Video
50%
Pathogenic Variants
50%
Breast Cancer Susceptibility Gene 1 (BRCA1)
33%
Germ Cells
33%
PARP Inhibitor (PARPi)
16%
Ovarian Cancer
16%
Cancer Prevention
16%
Learning Media
16%
BRCA Testing
16%
Cell-free DNA (cfDNA)
16%
Upper Elementary School
16%
Precision Medicine
16%
Pathogenic mutations
16%
Opportunity to Learn
8%
YouTube Videos
8%
Educational Media
8%
Citizens Should
8%
Aunts
8%
Scientific Events
8%
Agora
8%
Triplet
8%
Educational Stages
8%
Inherited Retinal Dystrophies
5%
Copy number Variation Detection
5%
Calling Criteria
5%
Biochemistry, Genetics and Molecular Biology
Genetics
55%
Copy-Number Variation
50%
Retinitis pigmentosa
50%
Next Generation Sequencing
40%
Multiplex Ligation-Dependent Probe Amplification
15%
Genomics
6%